Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil effective-site concentration with remimazolam for hysteroscopy
ChiCTR2200064885Phase 4Not yet recruiting
- Sponsor
- Mengcheng County No. 1 People's Hospital
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remifentanil and remimazolam in menstrual disorders, sponsored by Mengcheng County No. 1 People's Hospital. Primary endpoints: Operation time, Recovery time and 4 more. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
remifentanilremimazolam
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on ChiCTR2200064885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064885.